All NewsFDA BriefsOncology IconsSpecial ReportsVoices from the Field
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
All VideosCase-Based Peer PerspectivesExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPivotal Practice Views with the Oncology BrothersPodcastsPrecision Medicine
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
CME/CE
Case-Based Roundtable SeriesClinical TrialsPartnersPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
eNewsletterPrint Subscription
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
Spotlight -
  • Biomarker-Driven Lung Cancer
  • GIST
  • HER2-Positive Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Small Cell Lung Cancer
  • Renal Cell Carcinoma
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
    • CME/CE
Advertisement

Skin Cancer

home / expert-perspective-tumor-board / skin-cancer
Advertisement

Case 1: 69-Year-Old Male With Locally Advanced cSCC

EP. 1: Case 1: 69-Year-Old Male With Locally Advanced cSCC

November 25th 2019

Watch


Case 1: Treatment Options for Locally Advanced cSCC

EP. 2: Case 1: Treatment Options for Locally Advanced cSCC

November 25th 2019

Watch


Case 1: Data Supporting Anti-PD-1 in cSCC

EP. 3: Case 1: Data Supporting Anti-PD-1 in cSCC

November 25th 2019

Watch


Case 1: Managing Patients With cSCC on Anti-PD-L1

EP. 4: Case 1: Managing Patients With cSCC on Anti-PD-L1

November 25th 2019

Watch


Case 2: BRAF-Mutated Metastatic Melanoma

EP. 5: Case 2: BRAF-Mutated Metastatic Melanoma

November 25th 2019

Watch


Case 2: Long-Term BRAF/MEK Data in Melanoma

EP. 6: Case 2: Long-Term BRAF/MEK Data in Melanoma

November 25th 2019

Watch

Advertisement

Case 3: Recurrent Metastatic cSCC

EP. 7: Case 3: Recurrent Metastatic cSCC

November 25th 2019

Watch


Case 3: Practical Management of Metastatic CSCC

EP. 8: Case 3: Practical Management of Metastatic CSCC

November 25th 2019

Watch


Case 4: Infiltrative Basal Cell Carcinoma

EP. 9: Case 4: Infiltrative Basal Cell Carcinoma

November 25th 2019

Watch


Case 4: Options Beyond HHI for Basal Cell Carcinoma

EP. 10: Case 4: Options Beyond HHI for Basal Cell Carcinoma

November 25th 2019

Watch

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.